|1.||Xiao, Yong-hong: 2 articles (03/2011 - 10/2008)|
|2.||Wang, Kun: 1 article (11/2012)|
|3.||Li, Yun-fei: 1 article (11/2012)|
|4.||Huang, Ji-han: 1 article (11/2012)|
|5.||Zheng, Qing-shan: 1 article (11/2012)|
|6.||Yin, Fang: 1 article (11/2012)|
|7.||He, Ying-chun: 1 article (11/2012)|
|8.||Wen, Ai-dong: 1 article (03/2011)|
|9.||Xiu, Qing-yu: 1 article (03/2011)|
|10.||Mao, Guo-guang: 1 article (03/2011)|
|1.||Bacterial Infections (Bacterial Infection)
03/01/2011 - "Antofloxacin hydrochloride tablet was effective and safe for the treatment of acute bacterial infections."
11/01/2012 - "The ratio of AUC from the PPK model vs MIC as the PD parameter can be applied in a dose-finding trial of antofloxacin in treatment of bacterial infections. "
01/01/2010 - "A phase II study of antofloxacin hydrochloride, a novel fluoroquinolone, for the treatment of acute bacterial infections."
11/01/2012 - "Dose findings of antofloxacin hydrochloride for treating bacterial infections in an early clinical trial using PK-PD parameters in healthy volunteers."
03/01/2011 - "To evaluate the clinical efficacy and safety of antofloxacin hydrochloride tablet for the treatment of acute bacterial infections. "
10/01/2008 - "Using the neutropenic murine thigh infection model, we defined the pharmacodynamic profile and property of antofloxacin hydrochloride against Staphylococcus aureus. "
10/01/2008 - "Pharmacokinetics/pharmacodynamics of antofloxacin hydrochloride in a neutropenic murine thigh model of Staphylococcus aureus infection."